Files

Document Type

Description

• Auto-inflammatory disorder occurring in affected children every 3-8 weeks.

• Onset around age 2; lasting into second decade of life.

• A current pathophysiologic theory is PFAPA is a disorder of the innate immune system involving interleukins, chemoattractants, and cytokines that stimulating the inflammatory response causing symptoms associated with PFAPA.

• Early diagnosis of PFAPA may help prevent the unnecessary use of antibiotics.

• Biomarker CD64, galectin-3 and the MPV may be useful in the diagnosis of PFAPA along with other laboratory values during the febrile attack period of PFAPA.

• Traditional and current treatment of PFAPA is single dose of corticosteroids at onset of symptoms.

• Treatment with tonsillectomy was found to have an 80% cure rate.

• No statistical difference between corticosteroid and tonsillectomy treatments.

• Treatment of PFAPA with antibiotics was found ineffective.

• Treatment of PFAPA with vitamin D, was found by one study to have promising results.